Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology

Inter-patient molecular heterogeneity is the major declared driver of an expanding variety of anticancer drugs and personalizing their prescriptions. Here, we compared interpatient molecular heterogeneities of tumors and repertoires of drugs or their molecular targets currently in use in clinical on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zolotovskaia, Marianna A., Sorokin, Maxim I., Petrov, Ivan V., Poddubskaya, Elena V., Moiseev, Alexey A., Sekacheva, Marina I., Borisov, Nicolas M., Tkachev, Victor S., Garazha, Andrew V., Kaprin, Andrey D., Shegay, Peter V., Giese, Alf, Kim, Ella, Roumiantsev, Sergey A., Buzdin, Anton A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084891/
https://www.ncbi.nlm.nih.gov/pubmed/32111026
http://dx.doi.org/10.3390/ijms21051580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084891/
https://www.ncbi.nlm.nih.gov/pubmed/32111026
http://dx.doi.org/10.3390/ijms21051580

Ejemplares similares